Canaccord thinks the standalone value for Olink (OLK) is $13-$15 per share if the pending acquisition by Thermo Fisher (TMO) at $26 per share were blocked today. The merger is logical, but there remains regulatory events that create uncertainty, the analyst tells investors in a research note. The firm points out the acquisition is under investigation in the UK with a decision coming on July 8. Canaccord keeps a Hold rating on Olink with a $26 price target following the “relatively mixed” Q1 report.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OLK: